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Dendritic epidermal T cells (DETC) are skin-specific 
members of the epithelial I'D T-cell family in mice. 
We have reported previously that the growth of 
DETC is promoted by interleukin (IL)-2 in an auto-
crine fashion, or by IL-7, which is secreted by neigh-
boring keratinocytes. Here we report that DETC 
growth is promoted by IL-15, a newly discovered 
T -cell growth factor that is produced in lymphoid as 
well as nonlymphoid tissues. Recombinant IL-15 pro-
moted the growth of the 7-17 DETC line in a time- and 
dose-dependent fashion. Using IDonoclonal antibodies 
against a-, 13-, or Yc-chains of the IL-2 receptor 
cOlTIplex, we observed that the combination of anti-J3 
chain and anti-y c chain antibodies blocked IL-15 
responsiveness completely, whereas anti-a chain had 
no effect. These results indicate that this I'D T-cell 
line uses the J3lyc heterodimer for proliferative re-
sponses to IL-15. Antibodies against IL-2 or IL-7 did 
D endritic epiderma l T cells (DETC) are uniquc le ukocytes that res ide I~ormally in the epidermis of murmc skll1 [1,2]. Stud lcs from our own and oth cr laboratories (revicwed in [3]) have led to the appreciation that DETC arc skin-specific mcmbcrs 
of the res ident e pithelial "10 T-cell fam ily (reviewcd in [4]). A 
critical q uestion concerns the mechanisms by which these "10 T cells 
are able to survive in nonlymphoid tissucs, such as epidcrmis [5] . 
Severa l yea rs ago, wc rcportcd that inte rle ukin (IL)-2, w hich is 
secretcd by DETC upo n activ ation [6,7], promotes the growth of 
DETC [S]. More reccntly, wc observcd that IL-7, whi ch is 
produced by n e ighboring keratinocytes [9-11] or by dermal6bro-
blasts [12,13] , serves as a second g rowth facto r for DETC [9,14]. 
Thus, DETC proliferation is supported by at least two mechanisms: 
a utoc rine through IL-2 and paracrine thro ug h IL-7 [15]. 
IL-15 is a 14-15-kD molecule originalJ y isolated from culture 
supe rnatants of thc sim ian kidney epithelial cell lin e CV-l/EBNA 
[16]. It is notable that this ncw cytokill c sh ares scveral biologic 
activitics with IL-2: 1) Both promotc the growth of the I L-2-
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not block IL-15-driven proliferation of 7-17 DETC, 
indicating that IL-15 promotes their growth in an 
IL-2- and IL-7-independent manner. Both the sur-
face expression of J3lyc heterodu'Ilers and the IL-15 
responsiveness of7-17 DETC were highest 1 to 8 days 
after concanavalin A stilTIulation, and both declined 
substantially 21 days after stimulation, illustrathlg 
regulation by the state of cell activation. Working 
with epiderlTIal cells that were freshly procured frOID 
CBA mice, we noted that IL-15 promoted conavalin-
A-triggered growth of Thy-1 + cells (i.e., DETC), but 
not of the Thy-l- cells. The Yc-chain was not ex-
pressed by freshly procured DETC, becoming detect-
able within 48 h after concanavalin A stilTIulation. 
We propose that IL-15 facilitates the growth of epi-
thelialyo T cells by a J3lyc receptor-dependent mech-
anism. ] Illvest Del'l/wtol 105:837-843, 1995 
dependcnt T - cell lin e, CTLL-2, and of CD4 -I- and CDS + T cells in 
pe ripheral blood; 2) both promote the generation of cytotoxic T 
cells; and 3) both use {3- and "I-chain s of the IL-2 receptor (R) 
complcx [16,17]. On the othcr h and, IL-15 differs fi'om IL-2 in at 
least two major respects. First, t hc IL-2R {3- and "I-chain het-
e rodimcr appea rs to mediate high-affinity binding of IL-15 [17] , 
whereas aU three chains, ct, {3, and "I, are req uircd for high-afrinity 
binding of IL-2 (reviewcd in [1S,19]). Sccond, IL-1 5 mRNA is 
cxpresscd prefere n tially in nonlymphoid tissucs (e.g., placenta, 
ske letalmusc1e, heart, lung, li ver, and kidney) but is not detectable 
in activated T ce ll s, w hi ch are the primary source of IL-2 [16] . 
Based o n these fcatures, we hypothesizcd tha t IL-15 may scrv e as a 
third re levant growth f.,ctor for the "18 T cclls that reside in 
nonlymphoid tissues. 
As m entioned, the IL-2R complex is composcd of at Icast three 
chains: ct, {3, and "I (reviewed in [lS,19]). Thc "I-ch ain is shared 
amon g at Icast fivc IL rcccptor complexes, i.e. , IL-2R [20-22], 
IL-4R [23,24], IL-7R [25 ,26] , IL-9R [27 ,2S] , and IL-15R [17]. 
T hjs comm on "I- chain ("I..) is expressed by th ymocytes. mature 
T cells, n cells, and natural killer cells [29 ,30], and it plays all 
essentia l ro le in T-cell development (reviewcd in [31 ,32]) , as 
cvidenced by the fll1din g that its mutation causcs X -linkcd scvcrc 
combincd immunodeficiency in humans [33 ,34]. Moreover, it is 
now evident t hat the "Ie-cha in, together with the {3-chain, is 
responsible for IL-2-dependent signal transdu ction [35-3S]. T h e 
second goa l of ou r study was thel:eforc to detel'l11ine whether 
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DETC express th e Yo- c h ain and, if so, to e lucidate its ro le in 
cytokine responsivcness. 
MATEJUALS AND METHODS 
Cells The long-te rm cultured DETC line, 7-17. was used in thi s study. 
Th.is line was estab li shed origina ll y fi'on1 fluorescencc-activated cel l sortcr 
(FACS)-purified DETC in AIU'l.. mice and expanded by repea ted restimu-
lation with cO ll c:\Iul va lin A (Con A; '1 J.Lg/ ml) and by feeding with ri L-2 
1'6,71. The culture mcdium was comp lete IUJM I supplemented with 
10'1., fetal bovine serum [6 1. T IllS li ne conta ins greate r than 98% DETC as 
judgcd by FACS ana lyses ll sing monoclona l antibody (MoAb) against the yeS 
T-ce ll receptor (PharMingen. San Diego, CAl or a Vy3 dete rminant 
(Pharmingen) 139]. Other characteri stics of this line have been described 
elsewhere [9. 14,40-43 1· 
DETC were also iso latcd ficesh ly fi'om CUA mice (10-1 6-week-old 
femal es; Jackson Laboratories , Bar Harbor, ME) as described previously 
144]. Briefly. epidermal ce ll s iso lated by two sequentia l tryps in treatments 
were enriched fo r DETC by centrifugation ovcr Histopaq ue (S igma C hcm-
ica l Co .. St. Louis, MO). Cell s recovered from the inte rface were sta ined 
with fluorescein isoth.iocyanate (FITC)-conjugated anti-Thy-1.2 MoAb 
(Becton-Dickinson , Mountain View, CAl and then sorted into T hy- I + (i.e., 
DETC) and Thy- 'I - populations . 
T he IL-2-dependent murine linc CTLL-2 was purchased from American 
Type C ulture Collection and maintained as described prcviously 1'61· 
Cytokines I-Iuman rlL-1 5 was purcha sed fi'om Pepro T ech Inc. (Rocky 
Hill, NJ). Murine r1L-1 2 was a kind gift from Dr. Sypek (Genetics IllStitutc , 
C ambridge, MA). Other cytokines were obta ined fro m R &D Systems 
(Minneapolis, MN) , Gibco-BRL (Grand Island , NY), or Genzyme (Cam-
bridge , MA). I3i o logic activities of these cytokines have been tested 
previously in other experimental systcms 1.6.9,1 4,39] . 
Proliferation Assays Pro liferative responses of 7-17 DETC or fresh ly 
isolated DETC wcre assessed by ' H-thymidine uptake , as described previ-
ously [6,9,14 ]. I3riefl y, cells we re cultured in complete R.PM I on round-
bottom 96-we\.l plates, pulsed with 1 J.LC i/well of "H-thymidine (New 
England Nuclear, I3 os ton, MA) for the last 16 h , and harvested using an 
automatcd ce ll harvcster. To assess the requirement for endogenous IL-2 o r 
IL-7 , anti-IL-2 MoAb (S4136) or polyc lonal antibodies against IL-7 (R&D 
Systems) were added to the microcultures [9] . To identi fY the receptors 
that mediate cytokine responsiveness, we added ami-IL-2R a-chain 
(3C7), anti-/3-chain (TM-I31) (both from [,harmingen) , or anti-yo MoAb 
(TUGm2) [23]. In some experiments, proliferative responses were assessed 
by counting cc ll numbers: 7-'17 DETC (5 X lOs cells/well) Wl!re culturcd 
in 24-wdl plates, harvested on da y 4 by a 3-min l!xposure to 1 mM 
cthylc I1 cdial11inctctraacc tic acid, and the n cOLIn ted in a h elllocyt0I11ctc r . 
Flow Cytometric Analyses To stud y the express ion of IL-21'l.. by 7-17 
DETC, we exposcd the cell s to MoAbs aga inst a-, /3- , or y .. -chains, 
fo llowed by stain ing with FITC-conjugated anti-rat IgG Oackson, West 
Grove . PAl . To examin e freshl y iso la ted DETC, epidermal ce ll s recoverl!d 
fi'om the I-listopaqlle/ medium interface were do uble sta ined with FITC-
conjugated anti-T hy- I .2 MoAb and with anti-receptor MoAbs followed by 
phycoe rythrin- labeled anti-rat IgG (Caltag, South San Francisco, C Al . 
Samples were ana lyzed with a FA CScan [39]. 
RESULTS 
IL-15 Promotes the Growth of 7-17 DETC W e first exam-
ine d a pancl of c ytokines, including IL-15, for th eir impact o n the 
growth of th e long-tcrm DETC line, 7-17 (Fig 1). Amon g 25 tested 
c ytokin es, IL-2 , lL-7 , and IL-15 each demonstra ted a potent abi li ty 
to promote the growth of 7-17 DETC. By contrast, a ll oth er 
cy tok.ines ex hibi ted li ttle if any efFect. IL-15-driven proliferation 
occ urred in a dose-depcndent manner, w ith D.1- ng/ml producing 
sign.ifi cant in c reases in " H-thymidine uptake (Fig 2). On th e other 
h and , the m agni tude of the I L-1 5 response, at the relatively low 
concentratio n range use d in thi s experiment, was modest compared 
with that of IL-2 or IL-7. T his is not att ributable to difFerences in 
the biologic activ it ies of the cytokines, b eca use IL-1 5 was equ al to 
I L-2 in promoting the growth of th c murin e a{3 T cell line, 
CTLL-2 . It is intc restin g that I L-7 was effective o nl y for 7 -1 7 
DETC, whercas IL-4 was active on ly for the CTLL- 2 lin e, dcm-
onstratin g distinct g rowth factor require ments for th ese two T - cell 
lin es. 
Added lL-15 promoted " I-I-thymidine up take by 7-1 7 DETC as 
early as day 2 and continuously for up to 7 d (Fig 3, I ~fl). Cell 
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Figure 1. Proliferative responses of 7-17 DETC to selected cyto-
kines. T he 7-17 DETC line (Con A activated 3 d ea rli er) (1 O~ cells/wcll) 
was cul tured in round-bottom 96-well platcs in thc presence of each of 25 
difFerent cytokines (10 ng/ml). Data shown arc the mean ::':: SEM (n = 3) of 
' I-I-thymidine uptake on da y 3. G-CSF, gran ul ocyte co lony-stimulating 
fa ctor; SCF, stem cell factor; PDGF, plate.lct-derived growth facto r; TNF, 
tumor necrosis f., ctor; MIl>. macrophage inflammato ry prote in ; IFN, intcr-
feron; TGF, transforming growth f., ctor; LlF, Icukemia inhibitory f., Ctor. 
numbers also in creased continuo usly for 8 d in the presen cc of 
lL-15, w h e re as no increase was observed in its absen ce (Fig 3, right). 
T hus, I L-15-driven cell g rowth was rapid and continuous in its 
k.ineti cs. 
Participation of the IL-2R {3- and Yc-Cha in Heterodimer ill 
the IL-15 Responsiveness of7-17 DETC Thc IL-2R yo-chain 
serves as an essentia l c lement in the lL-2R complex [20 - 22] and in 
receptor com plexes for IL-4 [23,24], fL-7 [25,26], and IL-1 5 [J 7]. 
Thus, it was of interest to examine surface express io n of the 
Yc- ch ai n by 7- 17 DETC. As noted in Fig 4, thi s celliinc did express 
th e Yc- chain in addition to th e a - and {3- ch ain s. W e a lso observed 
that y o- ch ain expression was regul ated by the state of cell activa-
tion; express io n levels wcre higher in "activated" cel.l s (Con A 
stimulated 1 d earlier) and " in termediate" cell s (stimulated 8 d 
earlier) compared w ith "resting" cell s (stimulated 21 d earli er). 
Express ion levels for th e a-ch ain Were regu lated in a simi.! ar 
manner. At each statc of activa t ion, 7-17 DETC respondcd differ-
entl y to IL-15 (Fig 5). IL-1 5-dependent proliferation was most 
ev ident for cells in th e " intermediate" state, w h ereas cells in th e 
" resting" state f.1iled to respond to fL-15. "Activ ated" cell s that 
h ad received Con A stimu lation 1 d e arlier exhibited profound 
proliferation in th e absen ce of adde d growth factors, and IL-15 
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Figure 2. Dose responses of cytokine-driven proliferation by 7-17 
DETC. Thc 7-17 DETC line (Call A activated 8 d earlier) (10" ce lls/ well) 
or t he IL-2-dcpendent lI1urine n(3 T-cell line CTLL-2 (3 X l O' cell s/ well) 
w a s cultured ill the presence or the indicated concentra tions or I L-2. LL-4, 
lL-7, or IL- 15. Data shown arc the mean :!: SEM (n = 3) or ' H-thymidine 
upt:lkc on day 3. 
produced o nly m o dest augm entatio n of their pro li feration. We 
interpreted this to re fl ec t their au tocrine response to [L-2 (and 
possibly other factors) that was pro du ced upo n Co n A stimulation 
[6]. N evertheless, these o bservatio n s indi cate that n o t o nly surface 
expression of y,.-receptors, but also [L-1 5 responsive ness, are 
regulated b y th e sta te of ce ll activatio n. 
W e then used MoAbs against the 0'-, {3- and Yc- chains of the 
IL-2R compl e x to determine the co mpositio n respo nsible for lL- '15 
responsiveness by 7-17 DETC. (L-1 5-dri ven prolife ratio n was 
blocked in a dose-dependent fas hio n b y e ithe r anti-J3- chain o r 
anti-yc-chain M oA b , but not b y anti-a - c hain MoAb (Fig 6, lop) . 
By contrast, (L-2-driven proliferation was inhibited by each of th e 
three M oA bs, va lidating the ir blocking potential. Moreover, the 
combinatio n of anti-yc- chain and anti-{3- chain MoAb blocked 
comple te ly th e pro life rati ve respon se of 7-17 DETC to IL-15 (Fig 
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F igure 3. Kinetics of IL-15-driven proliferation by 7-1 7 DETC. 
The 7-17 DETC linc (Can A activated 8 d earli cr) lVas cultured in 96-we ll 
pl ates CI 0" ccll s/ we ll ) (ltji) or 24-wcll plates (5 X lOs cells/ well) (rig"l ) in 
the presence or absence or 1L-15 (10 ng/ ml). Data shown arc .1 H-thY11lidine 
upt<1ke (i<j i) or mean ce ll numbcrs (r(Q"t) from triplicate cul tures . 
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Figure 4. Surface expression of the 'Ye-chain by 7-17 D ETC. T he 
7- 17 DETC line. Can A activated 1 d (acriv:lted). 8 d (intcnncdiate). or 21 
d (resting) berore assay. was stained with MoA b against each chain o r the 
IL-2 R complex (closed ilisfOgrn lll s) or with isotype-matched contro l 19G (OpCII 
"istoSl'tlllls). 
6, &0 /1 0111). Contro l [gG showed onl y n egligible effects on eith er 
IL-15- Or IL-2-dri ven proliferation . T hese results indicate that the 
heterodime r composed of {3- and y .. - chain s mediates the [L-1 5 
respo n siven ess of DETC. 
Because 7-17 DETC pro du ce re lative ly large amounts of IL-2 
(upon activation) and express constitutively IL-7 mR.NA r6 ,45], we 
n ext so ught to de te rmine whether their proli ferative respon ses to 
IL-15 might require these endogenous g rowth fa c to rs. As sh own in 
Fig 7 , anti-IL-2 or allti-I L- 7 an tibodies blocked the proliferation 
driven b y IL-2 or IL-7, respectively, thereby va lidatin g the neutral-
iz ing capacity of these an tibodies . It is important that IL- 15-dri ven 
proliferation w as block ed b y neither anti-[L-2 nor anti-IL- 7 anti-
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Figure 5. Regulation of IL-15 responsiveness by the state of acti-
vation . T he 7- 17 DETC line , Con A activated 1 d (acti vated). 8 d 
(interm cdiate) , or 2 1 d (res ting) earli er. was tested fo r pro li te rative respon-
siveness to I L-2. IL-7, or I L-lS (10 ng/ ml). Data shown arc the mcan + 
SEM (n = 3) or JI-I -thYlllidinc up take on day 2. 
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Figurc 6. Participation of 1'<- and (l-chains in IL-15-drivcn prolif-
cration by DETC. The 7-17 DETC line (Con A activated 8 d earli er) was 
tested for proliferative responsiveness (day 3) to 3 ng/ml IL-1 5 (rlosed bors) 
or 1 ng/ ml I L-2 (s IriJled bors) in the presence of each of an ti-(.l'-, 13-, o r 
Yc-chain MoAb ilt the indicated concentrations (1o!,) . Control ' H-thymidine 
L1ptake in the absence of MoAbs was 1.920 ± 150 Cplll (no cytokine), 
10,500 ± 1,050 cpm (IL-15), and 29,1 00 ± 1,000 cpm (IL-2). Altern ative ly, 
proliferati ve responses (day 3) of 7-17 DETC to 3 ng/ml I L-1 5 were 
measured in the presell ce of anti-yc (30 J.Lg/ml) and /o r anti-(l-chain MoAb 
(30 J.Lg/ml) (I")/fOIlI). Statistically significant differences from IL-15 alone: 
*p < 0.05; ** p < 0.01. 
bodies. We thus conclude that IL-1 5 promotes the growth of thi s 
DETC lin e in an IL-2- and IL-7-independent m anner. 
Expression of the Yc-Chain and IL-15 Responsiveness of 
DETC Freshly Procured From Skin A cri t ica l question con-
cern s the role of IL-15 toward DETC ill /li llO, and thus w hether 
IL-15 promotes the growth ofDETC that are freshly procured fi·om 
skin. Epiderm al ce ll s isolated £i·om CBA mi ce were FACS- sorted 
into T h y- l • (DETC) and T h y-l - populations and th e ll tested for 
proliferative responsiveness. As noted in Fig 8, th e T h y-1 + cell s 
proliferate d vigorously iJl the prese nce of Con A alolle; this 
Anti -IL-2 
Anti-IL-7 
Control IgG 
(rat) 
IL-2 IL-7 IL-15 
3H-Thymidine Uptake (cpm x 10- 4) 
Figure 7, Independence of IL-15 responses by 7-17 DETC to 
cndogcnous IL-2 and IL-7 . The 7-17 DETC line (Con A acti vated 8 d 
ea rlier) was examined for proliferative responses to IL-2 (1 ng/ml), IL-7 (1 
ng/ml), or IL-1 S (3 Ilg/ml) in the presence of rat anti-I L-2 MoAb (3 
J.Lg/ml), polydonal goat anti-IL-7 antibodies (30 J.Lg/ml) , or control 
antibod ies. Data shown arc the mean ± SEM (n = 3) of'H-thymidine 
uptake on day 3. Proliferative responses in the presence of control goat IgG 
were indistinguishable 6·om those with control rat IgG . Baseline prolifera-
tion in the absence of added growth facto rs was 2005 ± 95 cpm . 
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Figure 8. IL-15 rcsponsivcness of DETC freshly procured from 
skin . In te rface epid ermal ce ll s iso lated fro l11 C I3A mice were FACS-
sorted in to Thy- l + and T hy- ·I - populations . Cells were then cultured in 
96-well pla tes (2 X 10·' T hy-l + ce ll s orl. 2 X 105 Thy-l - ce ll s/well) in 
the presence or absence of Con A (2 J.Lg/ml) and/or I L- l 5 (10 ng/ml ) . 
Data show n are the mean ± SEM (n = 3) of ' H-thymidinc uptake on 
day 7. 
response is mediated primarily by IL- 2 that is secreted b y DETC 
upon activa t io n [6,8] . T hi s Con-A-trigge rcd proliferation was 
enh anced sig nifi cantly (three- to fo urfo ld) by added IL-1 5. The 
T hy-l + cells did n ot pro life rate in response to IL-1 5 alonc, 
indicating the rcqui rement for ce ll activatio n sign als. By contrast, 
the T h y-1 - e pidermal ce ll s, whic h contain kerat inocytes and 
La ngcrhan s cells, d id not proliferate in rcsponse to IL-1 5, even in 
th e presence of Con A. T hese res ul ts indi cate that afte r Con A 
stimula tio n , DETC are the major epide rmal cell s that proliferate in 
response to IL-1 5 . 
Having confirme d the IL-15 responsiv e ness of Con-A-p ulsed, 
fi·e sh DETC, we sough t to determine w hether they exp ressed the 
Yc- ch ain . First we examin ed, b y double sta ining, Yc- ch ain ex pres-
sio n within the T h y-l + epiderma l ce ll population (gated in the 
FL-1 channe l). As seen in Fig 9, the Yc- c hain was not detectable on 
Thy-1 + cells that were freshly procured from epide rmis. It is 
unlikely that this absence reflecte d degradati on of surf.Ke Yc- chain 
by th e trypsin u sed fo r cell procu re m en t, b ecau se of the 
following: (1) T h e Yc-chain re m ain e d undetectabl e on the 
T h y-1 + ep iderma l cell s even after 48 h in c ul ture (Fig 9, lOp); 
and (2) the Yc-chain remained detectable o n th e 7-17 DETC 
lin e, evell afte r expos ure to trypsin (Fig 9, bO/lOIIl) . R ather, we 
in te rp ret these obse rvati o n s to indi cate that DETC ill sitll do not 
express the Yc- ch ain con stitutively and that they acquire its 
exp ress io n on ly after receiv in g a rel eva n t activ atio n sig n al. T hi s 
conclu sio n was supp o rted b y t he observatio n that t he Yc- chain 
beca m e d e tectabl e o n t he Thy-1 + e piderm a l ce ll s within 48 h 
afte r Co n A sti mulati o n (Fig 9, top). 
D ISCUSS ION 
T he presen t study documents a n ew m echanism that facilitates the 
growth of y8 T cells that res ide in e pithe lial tissues. Working with 
a skin- specific member of this fa mil y (DETC), we have demon-
strated that IL-1 5 can promote the g rowth of th ese y8 T cells. 
T issue-resident y8 T cell s have been fo und in seve ral difFe rent 
tissues, including skin [7,46], intestine [47, 48], lung [49,50] , female 
reproductive tract [51], mammary g land [5 2] , and placenta [53]. 
IL-15 may be produced loca lly in at least som e of these tissues , with 
mRNA express io n for IL-1 5 confirmed to be present in both lung 
and pla centa [16]. M oreover, we h ave o bserved recently that 
epidermal keratinocytes produce 1L- 15 in respon se to exogen o us 
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Figure 9. Surface expression of the 'Ye-chain by freshly isolated 
DETC. Top. interfi,ce epidermal cells isolaccd from CI3A mice were 
double-stained with FITC-conjugated anti-Thy- 'I MoA b and then with 
anti-'Ye-chain (closed "istograll/s) or controli gG (Opl'lI ilis/ograll/ s) . followed by 
phycoerythritl-conj uga ted secondary antibodies. In some experiments. in-
cerfacc epiderlllal ce ll s were cultured ill the presence o r abse nce of COil A 
(3 J.Lg/ ml) for 48 h before sta ining, Data shown arc histograms of )',.-chain 
expr ession by the T hy-l ' population. Bottoll/ . to detc rmine the trypsin 
sens iti vity of surfa ce ), .. -chains. 7-'1 7 DETC were treated with O.3'Yu tryps in 
for 10 min at 37°C before staining. 
s tinluli.-j' Thus. our data introdu ce the concept that loca ll y pro -
duced IL- 1 5 ma y serve as a re levant growth facto r for epithe lial 
ti ssu e-type '18 T cells. 
A n alternative source of IL-15 in epithelia l tissues ma y be the '18 
T cell s themse lves. IL-15 resembles IL-T, a recently discovered 
T-cell g rowth factor, in several respects, in cludin g the fo llowing: 
(1) m o lecular size (14-15 kD for IL-15 and 12-16 kD for IL-T), (2) 
biologic activity (both pro m ote proliferation of the CTLL line, and 
both suppo rt the gene ration of lymphokine-activated kill e r activi-
ty), and (3) receptor composition (bo th bind to the (3- and 'Ie- chain 
heterodime r) [1 6, 17.54,55 ). On th e othe r hand. the sources of 
IL-15 and IL-T appear to be quite different. lL-1 5 was iso lated 
o riginall y fi' o m e pithelial ce ll lines, and IL-l5 mRNA is expressed 
primaril y in non lymphoid tissues, but not by activated T cells [16]. 
By contrast, IL-T was isolated originally from an adult T-cell 
le ukemia cell line, HuT-102 , and it promo tes the g rowth of tillS 
T - c ell lin e by an autocrine m echanism [54]. T hus, it is poss ible th at 
IL-15 and IL-T are closely re lated , ifnot identical molecules. It wi ll 
be important to dete rmin e w hether tissue-resident )'8 T cells, upon 
receiving relevant stimuli , secrete bio logica ll y impo rtant amounts 
ofIL-1 5/1L-T. 
We obscrved that both freshly isolated DETC and the 7-17 
DETC line req uire Con A stimulation for the acquisition and / o r 
maintenance of the ir IL-15 responsiveness. FACS-purified Thy-1 ' 
epidermal cells responded to IL-1 5 o nl y when activated w ith Con 
A. L ikc wise, 7-17 DETC ex hibited IL-15 responsiveness only w he n 
tested shortl y (1- 8 d) after Con A stimul ation. It is illtcresting that 
surface ex press io n of the 'Ie-chain was also regu lated by Con A 
stimulatio n in a similar fashion. Fresh DETC did n ot express 
d etectable 'Ie-chain mol ecul es bu t acquired them w ithin 48 h after 
Con A stimulation, and 'Ie- chain express io n by 7-17 DETC w as 
most evident shortly after Con A stimulatio n. Thus, surface expres-
sion of the 'Ie- chain and IL-15 respo nsiveness arc regul ated in 
t Mohamadzadeh M. Takashima A. Dougherty I, Kllop J. Bergstresser 
PR, Cruz PO Jr: Ultraviolet 13 radiation upregulates the expressioll of IL-15 
in huma" skin (manuscript submitted) . 
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para lle l after Con A stimulatio n. A ca usal relatio n of these two 
even ts was supported by the o bservation that an ti-Ye- chain MoAb, 
together with anti-{3-ch ain MoAb, blocked completely the ir pro-
life rati ve respo nses to IL-1 5. In this regard, we have reported 
prev io usly that DETC fi'cshly procured fro m skin , which ordinarily 
lack surface expressio n of the IL-2R a - ch ain, pro life rative respon-
siveness to IL-2, and IL-2 mRNA ex prcss io n. acquire all three upo n 
stimula tio n with Con A [45,56). Thus, it is like ly that the absen ce 
of I L-2 R Ye- chain expression and o f IL-15 responsiveness l'e Rects 
the fact tha t DETC ill S;/II arc in a relative ly restin g state. In thi s 
scenario, our data also suggest that DETC ;11 s;t/l m ay acquire, upo n 
acti vatio n. the capacity to proliferate in respo nse to IL-15 by a 
(3 1 'Ie -receptor- dependent m echanism . 
With respect to expression of the 'Ie-chain during T-cell devel-
opment, an early murine pre-T - ce ll population derived fi'om 
day-l3 fetal live r has been re po rte d to express this receptor at least 
in mRNA levels [17). T he maj o ri ty of CD4 - I CDS - thymocytes in 
day-15 fetal thymus express con stitutive ly th e 'Ie- chain o n the 
surh, ce [29.57) . These thym ocytes, which appear in the first wave 
of T-cell develo pment, are though t to con ta in the precursors of 
DETC, as judged by ex press io n of the sa m e T-cell receptor 
e lements (i. e., Vy3/ V 81) and by thei r abi li ty to recon stitute the 
DETC network in skin after transp lantation [58,59). Cons titutive 
e xpressio n of the )Ie- chain h as also been o bserved for both thymo-
cytes and spl enic T ce lls in adult mice [30,57). In this regard , the 
absen ce of 'Ie- ch ain o n DETC fTeshly procured from adult mice is 
unusual and m ay reRect a uniqu e mic roen viro nment of the skin as 
a no nlympho id tissue. V cry recently, Cao el al r 60) have demon-
stt'ated that targe ted disruptio n of the )'e- gene results in defec tive 
lympho id development in mice. producing the clinica l abnormali-
ties and patho logic features th at are o bserved in patients with 
X -linked severe combined immunodeficiency. Most impo rtant. 
DETC were compl e tel y absent in th ose mice that lack ed th e 
'Ie- gene . T hus, our results, together with these o bservatio ns , 11 0W 
validate the ne w concept that 'Ie-receptors pla y an essential ro le in 
development of the DETC network in skin. 
It is known that m od ul ation of the ep ide rmal microen viro nm ent 
leads to the activation ofDETC. For instance, topical application of 
an irritant chemi ca l (croton o il) o r an tioxidants (butylated hydroxy-
toluene) ca uSeS the ;/1 silll activ atio n of DETC, as eviden ced by 
in creased cell numbe rs and the acquired expressio n of IL-2 R 
a - chains [5 6,6 1] . Likewise, DETC de nsities arc m arkedly increased 
by the local injectio n of autoreactive, cytotoxic T - cell clones [62) . 
Stud ies arc in progress in o ur laboratories to determine w h ethe r 
these stimuli trigger the surface expressio n of the (3 / Yc-recepto rs by 
DETC and lor th e e leva ted secretion of IL- 15 b y n e ighbo rin g 
ke ratinocytes. Finally, IL-1 5 and IL-T have been shown to support 
the gen eration of no n-maj o r histoco mpatibility complex-restricted 
cyto tox icity [1 6,54]. In thjs regard, DETC are known to acquire a 
marked cytotoxic capac ity against skin tum o rs after culturin g with 
exogenous IL-2 [6,43,63 ,64). T hus, it will be important to deter-
mine whether lL-1 5 supports n ot on ly proli fe ratio n, but also the 
acquisition of cytotoxic capacity by DETC. Nevertheless. th e 
present study provides a conceptual basis for future stud ies th at 
address the physiologic ro les pla yed b y (3 / Ye-receptor-mediated 
IL-15 responsiveness in the biology of ep ith e lial tissue-resident y8 
T cells. 
HIe ",;sh to Iha"k Bffl)' Jall t's )()I' Ita s,,!,erb sC(f{'tariaJ assist alice. This ,,,,,rl..· '/Ins 
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